Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
Clinical trial NCT03685344 · TERMINATED
Trial details
- NCT number
- NCT03685344
- Sponsor
- ADC Therapeutics S.A.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-04
- Primary completion
- 2020-10-27
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.